Welcome to Drug and Alcohol Treatment
| ||
Addiction Treatment Drug Fda Approval Article
This is a selection made from among articles on Addiction Treatment Drug Fda Approval. For a permanent link to this article, or to bookmark it for future reading, click here.
What Everyone Ought To Know About Alcoholism Recovery
from: Alcoholism is one of the most common addictions in the present-day world. Once an alcoholic has identified him or herself as such, then it’s time that they reach out for help for their addiction. In many cases, the alcoholic’s family or friends have to take the first step in getting the addicted person into a recovery state. Sometimes an intervention is staged, where the alcoholic is given an ultimatum: go to rehab or get out of our lives. Other times, simply speaking concern to the alcoholic can snap them back to reality and make them realize that their addiction has progressed into a disease and is affecting others.Once an alcoholic is ready to seek help for his or her addiction, he or she must choose how to stop drinking. One of the more popular ways to rehabilitate an alcoholic is by implementing detoxification. Detox is going “cold turkey;” this is when an alcoholic abruptly stops drinking alcohol. Also, this cold turkey approach is used in conjunction with different drugs which are used to minimize withdrawal symptoms. Detox happens in a rehabilitation center setting; this is where a detox may be the most effective, as rehab centers are fully stocked with the drugs and staff needed to help an addict get off of his or her drug.
Detox can happen in many different ways, depending upon the degree of addiction present in the alcoholic. Drug treatment centers use detoxification to help to treat the physical effects of prolonged alcohol use, but it doesn’t treat the actual disease of alcoholism. At a drug treatment center, detox commonly takes about a week to complete; after this time, the patient will not experience the extreme physical withdrawal symptoms. After a patient is finished with detox, relapse may occur, especially if the recovering alcoholic receives no further addiction treatment.
One further treatment that many alcoholics participate in at rehab centers and elsewhere is group therapy or psychotherapy to help combat the mental ailing that often accompanies rehab from alcohol. These group therapy meetings will also give the recovering alcoholic the tools that he or she needs to combat his or her addiction and prevent relapse. The most popular group therapy is Alcoholics Anonymous, but there are many other support groups to aide in addiction recovery.
However an alcoholic gets addiction help, it’s important that he or she follow their rehabilitation through to the end. There is help out there for the addicted to come clean; it’s just a matter of him or her finding it.
About Author
Addiction.com is an admired resource for those struggling with an addiction. Addicted.com offers widespread information regarding how to choose a drug treatment center that is right for you.
Source: ArticleTrader.com
Addiction Treatment Drug Fda Approval Specific links
Addiction Treatment Drug Fda Approval News
New editorial offers clarity on confusing drug and alcohol addiction terminology
A new editorial released this week offers clarity and structure on confusing drug and alcohol addiction terminology for prescribers, users and regulators. "Through a glass darkly: can we improve clarity about mechanism and aims of medications in drug and alcohol treatments?" is published in the Journal of Psychopharmacology, the official journal of the British Association for Psychopharmacology ...
Read more...FDA Approves BYDUREON™ -- The First and Only Once-Weekly Treatment for Type 2 Diabetes
SAN DIEGO and DUBLIN, Jan. 27, 2012 /PRNewswire/ --Â Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN - News) and Alkermes plc (Nasdaq: ALKS - News) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Read more...Super painkiller raising concerns among drug abuse treatment community
Therapists working to get users off their addiction to prescription drugs are worried about a new super painkiller called Zohydro, which is now awaiting approval from the Food and Drug Administration.
Read more...Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Adults with ...
PHILADELPHIA, Feb. 7, 2012 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the ...
Read more...Vyvanse(R) (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Adults ...
PHILADELPHIA, February 7, 2012 /PRNewswire/ --Vyvanse (lisdexamfetamine dimesylate), an approved treatment forAttention-Deficit/Hyperactivity Disorder (ADHD) in patients ages 6 and above, is the first ...
Read more...Medicure Provides Update on TEND-TD Phase II Clinical Trial
WINNIPEG, MANITOBA-- - Medicure Inc. is pleased to provide an update and announce the addition of a site in India for its ongoing Phase II Clinical Trial, TardoxalTM for the Treatment of Tardive Dyskinesia . The company has received approval from the Drug Controller General of India and anticipates enrollment ...
Read more...Journey Healing Centers Raises Red Flags over New Super Painkiller Zohydro
With approximately 7 million Americans admitting to the non-medical use of prescription painkillers during the past month (U.S. Department of Health and Human Services), Journey Healing Centers (private drug and alcohol treatment centers) is raising red flags over the dangers of Zohydro, the newest super painkiller, said to be 10 times the strength of Vicodin and pending FDA approval ...
Read more...FDA approves product label change for Biogen Idec's TYSABRI to treat MS
Today Biogen Idec and Elan Corporation, plc announced that the U.S. Food and Drug Administration (FDA) has approved a product label change for TYSABRI that will help enable individual benefit risk assessment for patients with multiple sclerosis.
Read more...Titan Pharmaceuticals Announces Positive Results of Six-Month Open-Label Safety Retreatment Study of Probuphine
SOUTH SAN FRANCISCO, CA-- - Titan Pharmaceuticals, Inc. today announced the results of an open-label, six-month safety re-treatment study of patients with opioid dependence who previously completed a full ...
Read more...Scientists identify molecular switch that controls ATF2's dual functions
The National Cancer Institute (NCI) estimates that as many as one in 51 men and women will be diagnosed with melanoma-the deadliest form of skin cancer-at some point during their lifetimes. A research team led by Ze'ev Ronai, Ph.D. at Sanford-Burnham Medical Research Institute (Sanford-Burnham) is working to unravel the molecular mechanisms underlying the development and progression of this ...
Read more...